dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate

C18H24O10S — CID 101242586

IUPACdimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate
SMILESCOC(=O)C(C(=O)OC)[C@H]1[C@H](OC)O[C@H](CO)[C@@H](O)[C@@H]1S(=O)(=O)c1ccccc1
InChIInChI=1S/C18H24O10S/c1-25-16(21)13(17(22)26-2)12-15(14(20)11(9-19)28-18(12)27-3)29(23,24)10-7-5-4-6-8-10/h4-8,11-15,18-20H,9H2,1-3H3/t11-,12-,14-,15-,18-/m1/s1
InChIKeyXBZXVHAWOVHISQ-AJKMGBEJSA-N
MW432.45 g/mol
LogP-0.87
Rot. Bonds7

About dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate

dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate (PubChem CID 101242586) has the molecular formula C18H24O10S and a molecular weight of 432.45 g/mol. Its IUPAC name is dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate.

Molecular Properties

Compound Namedimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate
PubChem CID101242586
Molecular FormulaC18H24O10S
Molecular Weight432.45 g/mol
Exact Mass432.11
IUPAC Namedimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate
SMILESCOC(=O)C(C(=O)OC)[C@H]1[C@H](OC)O[C@H](CO)[C@@H](O)[C@@H]1S(=O)(=O)c1ccccc1
InChIInChI=1S/C18H24O10S/c1-25-16(21)13(17(22)26-2)12-15(14(20)11(9-19)28-18(12)27-3)29(23,24)10-7-5-4-6-8-10/h4-8,11-15,18-20H,9H2,1-3H3/t11-,12-,14-,15-,18-/m1/s1
InChIKeyXBZXVHAWOVHISQ-AJKMGBEJSA-N
XLogP-0.87
TPSA145.66 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500432.45
LogP ≤ 5-0.87
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate?
The IUPAC name of dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate (CID 101242586) is dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate.
What is the SMILES notation for dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate?
The canonical SMILES for dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate is COC(=O)C(C(=O)OC)[C@H]1[C@H](OC)O[C@H](CO)[C@@H](O)[C@@H]1S(=O)(=O)c1ccccc1.
What is the InChIKey of dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate?
The InChIKey is XBZXVHAWOVHISQ-AJKMGBEJSA-N. The full InChI is InChI=1S/C18H24O10S/c1-25-16(21)13(17(22)26-2)12-15(14(20)11(9-19)28-18(12)27-3)29(23,24)10-7-5-4-6-8-10/h4-8,11-15,18-20H,9H2,1-3H3/t11-,12-,14-,15-,18-/m1/s1.
What are the key properties of dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate?
dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate has a molecular weight of 432.45 g/mol, XLogP of -0.87, 7 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for dimethyl 2-[(2R,3S,4R,5R,6R)-4-(benzenesulfonyl)-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]propanedioate is sourced from PubChem (CID 101242586), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).